A detailed history of Squarepoint Ops LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 715,312 shares of GH stock, worth $20.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
715,312
Previous 373,043 91.75%
Holding current value
$20.3 Million
Previous $10.1 Million 46.24%
% of portfolio
0.03%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$17.13 - $26.91 $5.86 Million - $9.21 Million
342,269 Added 91.75%
715,312 $14.8 Million
Q4 2023

Feb 14, 2024

BUY
$21.58 - $29.5 $8.05 Million - $11 Million
373,043 New
373,043 $10.1 Million
Q1 2023

May 15, 2023

BUY
$22.92 - $33.76 $5.96 Million - $8.78 Million
260,035 New
260,035 $6.1 Million
Q3 2022

Nov 14, 2022

SELL
$43.66 - $61.0 $5.92 Million - $8.27 Million
-135,549 Reduced 91.63%
12,376 $666,000
Q2 2022

Aug 15, 2022

BUY
$28.82 - $77.35 $3.45 Million - $9.27 Million
119,802 Added 425.99%
147,925 $5.97 Million
Q1 2021

May 17, 2021

BUY
$127.04 - $179.1 $2.89 Million - $4.08 Million
22,769 Added 425.27%
28,123 $4.29 Million
Q4 2020

Feb 16, 2021

SELL
$99.96 - $135.93 $2.2 Million - $2.99 Million
-21,994 Reduced 80.42%
5,354 $690,000
Q3 2020

Nov 16, 2020

BUY
$80.32 - $111.8 $1.2 Million - $1.66 Million
14,880 Added 119.35%
27,348 $3.06 Million
Q2 2020

Aug 14, 2020

BUY
$60.49 - $97.5 $754,189 - $1.22 Million
12,468 New
12,468 $1.01 Million
Q4 2019

Feb 14, 2020

SELL
$59.49 - $82.78 $1.12 Million - $1.55 Million
-18,751 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$62.59 - $110.3 $932,152 - $1.64 Million
14,893 Added 386.03%
18,751 $1.2 Million
Q2 2019

Aug 14, 2019

BUY
$63.94 - $91.11 $246,680 - $351,502
3,858 New
3,858 $333,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.9B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.